Protected: Creating a more affordable and efficient vaccine development platform
Health Awareness June 21, 2022
Protected: Creating a more affordable and efficient vaccine development platform…
Health Awareness June 21, 2022
Protected: Creating a more affordable and efficient vaccine development platform…
Benzinga November 1, 2021
This Company has its Sights Set of Transforming the Pharmaceutical Industry With its Efficient C1 Vaccine & Drug Manufacturing Technology…
Wall Street September 8, 2021
The Vaccine Revolution Portfolio (MRNA, PFE, JNJ, NVAX, BNTX, AZN, DYAI)…
Wall Street August 31, 2021
Desperation on Variants Paints Path for Long-Term Vaccine Thesis (DYAI, MRNA, PFE, JNJ, NVAX, BNTX, AZN, SRNE)…
Wall Street August 12, 2021
Moderna bounces back with spotlight on other vaccine stocks (MRNA, DYAI, NVAX, JNJ, AZN, BNTX, PFE)…
Wall Street August 4, 2021
The Covid Vaccine Market is a Long Game in the Early Innings (BNTX, AZN, DYAI, NVAX, MRNA, PFE, JNJ)…
Wall Street July 28, 2021
Dyadic Int’l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in Development…
MarketWatch July 22, 2021
Delta Means Beta Testing Alpha Strategies in Biotech (NVAX, MRNA, DYAI, PFE, JNJ, BNTX, AZN, IBB)…
USA Today Special Edition July 19, 2021
See page 61 for: Dyadic applies novel C1 vaccine manufacturing platform based on Thermothelomyces fungus to develop vaccines & drugs against the coronavirus and emerging variants
For pdf click HERE…
MarketWatch July 13, 2021
Emerging Themes in the COVID-19 Vaccine Space (MRNA, PFE, DYAI, JNJ, NVAX, BNTX, AZN)…
MarketWatch June 9, 2021
Dyadic International (NASDAQ: DYAI): A Unique Approach to World Vaccination (DYAI, AZN, MRNA, NVAX, PFE, JNJ, BNTX)…
GENEDGE June 8, 2021
Off Message: Dyadic Fights Covid-19 with a Fungus…
MarketWatch June 2, 2021
The Vaccine Investment Hypothesis, and What’s Next (AZN, JNJ, DYAI, BNTX)…
MarketWatch May 26, 2021
Leading Vaccine Stocks Under the Microscope (PFE, NVAX, DYAI, MRNA)…
StreetInsider.com May 20, 2021
Could Dyadic International (DYAI) be a Dark Horse Vaccine MVP…
Wall Street May 12, 2021
DYAI’s C1 Technology May be Key in the Race to Vaccine-Induced Herd Immunity…
Elsevier Biologicals April 2021
Can a fungal platform be faster and cheaper than other platforms, enabling many cheaper and quicker therapeutics? Joris Vandeputte responded that the ZAPI experience shows that the fungal C1 system is a high-performance system, which can produce high quantities of apparently excellent antigens, in the appropriate conformation, and well glycosylated, which has been confirmed in animal…
MarketWatch April 28, 2021
Time for a New Vaccine Production Model? Spotlight on DYAI (NASDAQ: DYAI)…
Journal Transcript April 20, 2021
DYAI in Focus: Upstart Vaccine Maker Says has Faster Way to Vaccinate the World (AZN, MRNA, NVAX, PFE, JNJ, BNTX)…
StreetInsider.com April 9, 2021
Is Dyadic International Inc. (NASDAQ: DYAI) the Key to the Next Wave of Vaccinations? (NASDAQ: AZN) (NASDAQ: MRNA) (NYSE: PFE) (NASDAQ: NVAX)…
MarketWatch April 1, 2021
How Dyadic International Inc (NASDAQ: DYAI) Fits into the Vaccine 2.0 Gold Rush (NASDAQ: BNTX) (NYSE: JNJ) (NASDAQ: MRNA) (NYSE: PFE)…
StreetInsider.com March 30, 2021
Is Dyadic International Inc. (NASDAQ: DYAI) the Key to Scaling Up Global Access to a Viable Covid-19 Vaccine? (NASDAQ: NVAX) (NASDAQ: MRNA) (NYSE: PFE) (NASDAQ: AZN)…
Innovative Medicines Initiative March 24, 2021
A recipe for the next disaster: a new, pan-virus methodology for ramping up vaccine production
ZAPI have put in place a new pan-virus methodology for ramping up the production of new vaccines in the next crisis…
FinancialNewsMedia.com March 23, 2021
Covid-19 Pandemic Still Fueling Need for Increased Supplies & New Technology in PPE Markets…
Benzinga – Silvia Munoz Campo, December 10, 2020
Dyadic Biotechnology Is On A Quest To Find A Solution For COVID-19…
SNN / MicroCap Review Magazine Summer 2020
The Global Quest for A Vaccine Drives Dyadic’s C1 Adoption…
Proactive Investors, June 10, 2020
Dyadic and Frederick National Laboratory to develop C1 cell lines for coronavirus vaccine candidates…
Horizon, the EU Research & Innovation Magazine, April 7, 2020
Studying animal coronavirus defences is opening route to human treatments…
Innovative Medicines Initiative, March 30, 2020
ZAPI is laying the groundwork for the response to zoonotic disease outbreaks like COVID-19…
Animal Pharm Agribusiness, January 21, 2020
Quicker, cheaper, better is Dyadic motto…
BioProcess International, August 16, 2019
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system…
BioPharma-Reporter.com July 2, 2019
FDA should improve incentives to lower drug costs, says Dyadic CEO…
Tailwinds Research Group February 21, 2019
DYAI Looking Increasingly Compelling…
NBC News January 31, 2019
The shutdown is over – but not the pain for small businesses…
Manufacturing Chemist, January 30, 2019
Is the Production of Biologic Drugs Ready for an Overhaul?…
The Washington Post, January 23, 2019
Stuck in shutdown limbo, companies put IPOs on hold…
DGIwire January 11, 2019
Looking Beyond Mammals to Microbes for Tomorrow’s Drugs…
EuroLab Magazine, ScientistLive December 2018
Going Beyond CHO…
DGIwire December 3, 2018
Is a Fungus Among Us the Key to Tomorrow’s Biologic Drugs?…
DGIwire November 26, 2018
Building Better Biologics: A Challenge for the Biopharma Industry…
Science, November 16, 2018
Protein expression, revisited…
R&D Magazine / Pharmaceutical Processing, November 5, 2018
Fungal Strain Technology Could Disrupt Bio-Manufacturing Industry…
BioPharm International, November 1, 2018
Media Requirements for Different Cell Sources…
LSX Leaders (formerly known as BiotechandMoney), October 2018
Dyadic International: Working to Change the Game in Biopharma Manufacturing…
PharmTech.com, October 5, 2018
Biologic Drugs Challenge the Biopharma Industry…
Yahoo Finance, October 4, 2018
Undervalued Stocks You Can’t Afford to Miss…
Biocompare, September 27, 2018
CHO Cells: Beginning of the End or End of the Beginning?…
Pharmaceutical Manufacturing, September 25, 2018
Ditching the Model T for a Faster Ride…
BioPharma-Reporter.com, September 24, 2018
CHO cells the 1900s model car in a 2020 Tesla world, says Dyadic…
The Medicine Maker magazine, September 2018
The CHO’s Over: An Inflexion Point…